Cipla Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- 285, 286, 287, KIADB, IV Phase, Industrial area Bommasandra-Jigani Link Road, Bengaluru, Karnataka 560105, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3005857289 · DUNS 650442440
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-05-30
- VAIDrug Quality Assurance2020-01-24
- NAIDrug Quality Assurance2015-03-12
- NAIDrug Quality Assurance2011-11-17
Drugs this plant is listed as making
5 distinct drugs across 15 products name this site in their FDA label.
- Esomeprazole magnesiumCipla USA Inc.
- LenalidomideExelan Pharmaceuticals Inc.
- NilotinibCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.